Pfizer drug from Medivation deal shows promise in breast cancer ... - Reuters

Reuters
Pfizer drug from Medivation deal shows promise in breast cancer ...
Reuters
A breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior treatments and a ...and more »